Mr. Speaker, I appreciate the speech that my colleague has just given.
One issue that has not been touched on very much tonight is that in the midst of the shortage, the bottlenecks and the lineups was this absolutely shocking report about a clinic in Toronto, Medcan, getting access to the vaccine, and of course, then inoculating those clients of that clinic who had paid a very large user fee.
My question to the member is, what does he know about the situation? Why does he think it happened? What does he think can be done about ensuring that the rare supply of vaccine we have goes to those most in need?